CD274 and neoplasm: Our results showed an increase in MHCII expression in M2 macrophages within the tumor microenvironment of mice treated with dual PI3Kγ/PD-L1 inhibitors, suggestive of enhanced antigen presenting capabilities of tumor-associated macrophages are critical for optimal antitumor responses (Figure 4D–E).